Colorectal Cancer

  • R.S. Bresalier
  • S.B. Ho


Cancer of the colon and rectum (colorectal cancer) is a major cause of cancer-associated morbidity and mortality world-wide. It has been suggested that carcinogens introduced into the bowel act in concert with other luminal factors (e.g., bile acid and other tumor promoters) to affect epithelial cells in the colonic mucosa. Carcinogenesis is, however, a multistage process. Cells must be genetically primed (through either hereditary disposition or genotoxic events), must be induced to proliferate and must pass through a series of stages en route to immortalization and uncontrolled growth. Specific molecular changes related to enhanced cancer stage and metastatic potential have been identified. The diagnosis of colorectal neoplasms relies on screening strategies in patients without symptoms. These include the use of fecal occult blood testing with or without screening flexible sigmoidoscopy, radiological procedures or screening colonoscopy. Patients with symptoms of iron deficiency anemia, rectal bleeding or changes in bowel habits should be evaluated by colonoscopic examination. Treatment of colorectal cancer is by excision, either by colonoscopy for early lesions or by surgical means. Patients with evidence of extension of rectal cancer into the bowel wall or lymph nodes are treated with adjuvant chemo- and radiation therapies. Patients with colon cancer and regional lymph node métastases are treated with adjuvant chemotherapy. Chemotherapy of advanced disease has evolved, but is still often palliative. Rapidly evolving knowledge of the pathogenesis of colorectal cancer, especially in high-risk groups, is leading to the development of new tools for identifying which persons will benefit most from cancer surveillance and from adjuvant therapy following potentially curative surgery.


Colon Cancer Rectal Cancer Bile Acid Fecal Occult Blood Testing Barium Enema 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Baron JA, Beach M, Mandel JS, van Stolk RU, Haile RW, Sandler RS, Rothstein R, Summers RW, Snover DC, Beck GJ, Bond JH, Greenberg ER. (1999) Calcium supplements for the prevention of colorectal adenomas. N Engl J Med 340:101–107.PubMedCrossRefGoogle Scholar
  2. 2.
    Steinbach G, Lynch PM, Phillips RK, Wallace MH, Hawk E, Gordon GB, Wakabayashi N, Saunders B, Shen Y, Fujimura T, Su LK, Levin B. (2000). The effect of celecoxib, a cydooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 342(26):1946–1952.PubMedCrossRefGoogle Scholar
  3. 3.
    Grady WM, Markowitz, S. (2000). Genomic instability and colorectal cancer. Current Opinion in Gastroenterology 16:62–67.PubMedCrossRefGoogle Scholar
  4. 4.
    Watanabe T, Wu TT, Catalano PJ, Ueki T, Satriano R, Haller DG, Benson AB 3rd, Hamilton SR. (2001). Molecular predictors of survival after adjuvant chemotherapy for colon cancer. N Engl J Med 344(16):1196–1206.PubMedCrossRefGoogle Scholar
  5. 5.
    Imperiale TF, Wagner DR, Lin CY, Larkin GN, Rogge JD, Ransohoff DF. (2000). Risk of advanced proximal neoplasms in asymptomatic adults according to distal colorectal findings. N Engl J Med 343(3):169–174.PubMedCrossRefGoogle Scholar
  6. 6.
    Burt R. (2000) Colon Cancer Screening. Gastroenterology 119:837–853.PubMedCrossRefGoogle Scholar
  7. 7.
    Ahlquist DA, Skoletsky JE, Boynton KA, Harrington JJ, Mahoney DW, Pierceall WE, Thibodeau SN, Shuber AP. (2000). Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel. Gastroenterology 119(5):1219–1227.PubMedCrossRefGoogle Scholar
  8. 8.
    Sonnenberg A, Delco F, Inadomi JM. (2000). Cost-effectiveness of colonoscopy in screening for colorectal cancer. Ann Intern Med 133(8):573–584.PubMedGoogle Scholar
  9. 9.
    Winawer SJ, Stewart ET, Zauber AG, Bond JH, Ansel H, Waye JD, Hall D, Hamlin JA, Schapiro M, O’Brien MJ, Sternberg SS, Gottlieb LS. (2000). A comparison of colonoscopy and double-contrast barium enema for surveillance after polypectomy. National Polyp Study Work Group. N Engl J Med; 342(24):1766–1772.PubMedCrossRefGoogle Scholar
  10. 10.
    Saltz LB, Cox JV, Blanke C, Rosen LS, Fehrenbacher L, Moore MJ, Maroun JA, Ackland SP, Locker PK, Pirotta N, Elfring GL, Miller LL (2000). Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med 343(13):905–914.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2004

Authors and Affiliations

  • R.S. Bresalier
    • 1
  • S.B. Ho
    • 2
  1. 1.1515 Holcombe Boulevard — Unit 436Anderson Cancer CenterHoustonUSA
  2. 2.GI Section (111D)VA Medical CenterMinneapolisUSA

Personalised recommendations